Zepbound for Obesity-Related OSA Zepbound is FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity
If you drank too much the night before, stayed out too late, are fatigued from travel, recovering from sickness, or just didnt take in enough fluids during athletics activities, an IV hydration drip is a perfect response
Begin the conversation by asking what a healthy weight range is for someone of your age, height, and medical history
Regular follow-up to assess benefits versus harms helps guide continued therapy and safe discontinuation when necessary appropriately
And the agency has warned about companies illegally selling unapproved products containing semaglutide, tirzepatide or retatrutide falsely labeled "for research purposes" or "not for human consumption." As of May 31, 2026, the FDA had received 990 adverse event reports associated with compounded semaglutide and more than 730 associated with compounded tirzepatide